<DOC>
	<DOCNO>NCT01262729</DOCNO>
	<brief_summary>In clinical trial check , whether 2 hour ventilation xenon neuroprotective effect patient hospital cardiac arrest successful cardiopulmonary resuscitation</brief_summary>
	<brief_title>Xenon Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation</brief_title>
	<detailed_description>Patients hospital cardiac arrest successful cardiopulmonary resuscitation randomize two group . First group ( Treatment group ) inhalated xenon within 2 hour addition therapeutical hypothermia . The second group ( Control group ) treat therapeutical hypothermia accordance international guideline .</detailed_description>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>Patients hospital cardiac arrest successful cardiopulmonary resuscitation , treat Department Internal Medicine I , University Hospital Aachen Patients young 18 year Xenon allergy Pregnancy High expire oxygen requirement ( &gt; 70 % ) order maintain adequate arterial oxygen saturation ( SpO2 &gt; 94 % ) beginning treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>xenon inhalation</keyword>
	<keyword>therapeutical hypothermia</keyword>
	<keyword>patient cardiopulmonary resuscitation</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>